Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. (Q53718715)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
scientific article

    Statements

    title
    Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17369574
    retrieved
    18 May 2018
    reference URL
    http://europepmc.org/abstract/MED/17369574
    author

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q53718715&oldid=1835244031"